Search Results for keywords:"guidance"

Found 5 results

Search Results: keywords:"guidance"

💰 Only
Oldest Newest
  • 2025-00074 — Policy Statement on Class Action Complaints
    Type:Notice
    Citation:90 FR 1127
    Reading Time:about a minute or two

    The Federal Maritime Commission has issued a new policy statement allowing private parties to file class action complaints with the Commission. This policy clarifies that such complaints are permitted and may be evaluated using the Federal Rules of Civil Procedure when applicable. The policy aims to provide guidance to shippers and other third parties and can be accessed online.

    Simple Explanation

    The Federal Maritime Commission has a new rule that says people can join together in big groups, called class actions, to complain about certain things, and this rule is like a helpful guide on how they can do it using existing legal steps.

  • 2024-28266 — Sunshine Act Meetings
    Type:Notice
    Citation:89 FR 95247
    Reading Time:less than a minute

    The National Science Board announced a teleconference meeting of the National Science Board/National Science Foundation Commission on Merit Review. This meeting is planned for December 3, 2024, at the National Science Foundation in Alexandria, Virginia, and will run from 9:00 a.m. to 12:00 p.m. Eastern time. The meeting is closed to the public and will cover the discussion and approval of the final recommendations and guidance. For more information, Chris Blair can be contacted at cblair@nsf.gov or 703/292-7000.

    Simple Explanation

    The National Science Board is having a secret meeting on December 3, 2024, to talk about and agree on some important plans. They aren't telling us exactly what they're talking about or why the meeting is private, and if you have questions, you can ask Chris Blair.

  • 2024-31538 — Recommendations To Reduce the Risk of Transmission of Disease Agents Associated With Sepsis by Human Cells, Tissues, and Cellular and Tissue-Based Products; Guidance for Industry; Availability
    Type:Notice
    Citation:90 FR 1141
    Reading Time:about 7 minutes

    The Food and Drug Administration (FDA) has released new guidance aimed at reducing the risk of disease transmission caused by sepsis in human cell and tissue products. This guidance is designed to help organizations that make donor eligibility decisions by recommending practices to lower infection risks. The FDA issued this guidance immediately due to urgent health concerns, updating previous recommendations from 2007. The guidance reflects the FDA's current viewpoints but does not impose any legal obligations.

    Simple Explanation

    The FDA made a guide to help stop the spread of germs that can make people sick when they use special parts from human bodies, like cells and tissues. They want to make sure these parts are safe, especially because some germs can cause a serious illness called sepsis.

  • C1-2020-27872 — Proposed Guidance; Questions and Answers on Serving Children With Disabilities Placed by Their Parents in Private Schools
    Type:Proposed Rule
    Citation:86 FR 2615
    Reading Time:less than a minute

    The Education Department issued a correction to a proposed rule about serving children with disabilities who are placed by their parents in private schools. The correction updates the deadline for public comments from January 20, 2021, to January 21, 2021. This change was documented in the relevant Federal Register issue from December 21, 2020.

    Simple Explanation

    The Education Department said they made a tiny mistake about the last day people can say what they think about a new rule for helping kids with disabilities in private schools. They fixed the mistake by moving the last day to talk about it from January 20th to January 21st.

  • 2021-00189 — Potential Approach for Defining Durations of Use for Medically Important Antimicrobial Drugs Intended for Use In or On Feed: A Concept Paper; Request for Comments
    Type:Notice
    Citation:86 FR 1979
    Reading Time:about 10 minutes

    The Food and Drug Administration (FDA) is seeking public comments on a concept paper regarding the use of medically important antimicrobial drugs in animal feed. The paper suggests a framework for how drug sponsors can define the duration of use for these drugs in food-producing animals, aiming to prevent antimicrobial resistance and promote public health. The FDA is particularly interested in input on the timelines and processes proposed in the paper and hopes to use the feedback to create draft guidance. Comments can be submitted electronically or in writing by April 12, 2021.

    Simple Explanation

    The FDA wants to make sure animals that give us food stay healthy by asking for people’s ideas on how long they should use certain helpful medicines correctly, so they don’t stop working. They are trying to figure out the best way to keep us healthy and would like everyone’s help by April 12, 2021.